Skip to content
NASDAQ · OPHTHALMIC GOODS

Innovative Eyewear Inc. LUCY

5 fiscal years on record · USD · FY2025 reported · SEC filings only
$2.7M
▲ 62.6% YoY
$-7.6M
$-7.3M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Our smart eyewear products enable the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform many common smartphone tasks hands-free. We currently offer seven different models under the Lucyd Lyte collection. Our Lucyd Armor product line provides all of the powerful features of Lucyd eyewear in stylish safety glasses designed for all-day wear.

Written from the business description in Innovative Eyewear, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 25 March 2026. Every sentence was checked against that document before publication.

Growth

USD 2.7M
Revenue, FY2025 · full 5-year series below
Revenue $M Net income $M
FY2025 · Revenue 2.7 · Net income -7.6
1M2M-3M-6M
202120242025
Compound annual growth
+59.2%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−285 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Net -285.2%
-500%
202120232025
ROE
FY2025 · ROE -83.6%
-500%-1000%-1500%
202120232025
Three returns, three denominators.
Return on capital employedNot available: we don't have a clean operating profit figure for this period.

Each USD of equity lost 84 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -7.3
-3M-6M
202120232025

Total assetsUSD 10.1M
EquityUSD 9.1M
CashUSD 6.5M
Current ratio9.03×

Equity funds 89% of total assets.

The 5-year record

5 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
LUCY, 5-year financial record
Metric 20252024202320222021
Revenue $B0.00.00.00.00.0
Operating income $B◌◌◌◌◌
EBITDA $B◌◌◌◌◌
Income tax $B◌◌◌◌◌
Net income $B−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−1.90−5.19−10.87−0.87◌
Dividend / sh $◌◌◌◌◌
Payout % — not applicable: no dividend—————
ROE %−83.6−106.0−139.1−268.5−1563.5
Shares out B0.010.000.010.010.01

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 24 reconciliationsAUDITED

Reconciled in 5 of the 5 fiscal years we could check. 28 checks were skipped: the balance sheet is not tagged before 2021. 15 checks were skipped: EPS is not tagged before 2022. 14 checks were skipped: revenue is not tagged before 2021.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityOphthalmic Goods
Listed onNASDAQ
Incorporated inFlorida
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2021

Share this section

Download image